CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
Europe - EPA:CLARI - FR0010386334 - Common Stock
4.34 EUR
+0.14 (+3.33%)
Overall CLARI gets a fundamental rating of 3 out of 10. We evaluated CLARI against 31 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of CLARI have multiple concerns. CLARI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
CLARI had negative earnings in the past year.
CLARI had a positive operating cash flow in the past year.
In multiple years CLARI reported negative net income over the last 5 years.
In the past 5 years CLARI always reported a positive cash flow from operatings.
1.2 Ratios
CLARI has a Return On Assets of -0.43%. This is amonst the worse of the industry: CLARI underperforms 83.87% of its industry peers.
With a Return On Equity value of -1.71%, CLARI is not doing good in the industry: 83.87% of the companies in the same industry are doing better.
CLARI has a Return On Invested Capital of 1.63%. This is amonst the worse of the industry: CLARI underperforms 83.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CLARI is below the industry average of 6.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROIC | 1.63% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
CLARI has a Operating Margin (4.80%) which is comparable to the rest of the industry.
CLARI's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 91.90%, CLARI belongs to the best of the industry, outperforming 96.77% of the companies in the same industry.
CLARI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLARI is destroying value.
CLARI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CLARI has been increased compared to 5 years ago.
The debt/assets ratio for CLARI has been reduced compared to a year ago.
2.2 Solvency
CLARI has an Altman-Z score of 0.63. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.63, CLARI is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
The Debt to FCF ratio of CLARI is 13.25, which is on the high side as it means it would take CLARI, 13.25 years of fcf income to pay off all of its debts.
CLARI's Debt to FCF ratio of 13.25 is in line compared to the rest of the industry. CLARI outperforms 41.94% of its industry peers.
CLARI has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
CLARI has a Debt to Equity ratio of 1.90. This is in the lower half of the industry: CLARI underperforms 74.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.41
WACC3.92%
2.3 Liquidity
A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
CLARI has a Current ratio of 0.67. This is amonst the worse of the industry: CLARI underperforms 80.65% of its industry peers.
CLARI has a Quick Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI has a Quick ratio of 0.65. This is in the lower half of the industry: CLARI underperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 |
3. Growth
3.1 Past
CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.49%, which is quite impressive.
CLARI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
Measured over the past years, CLARI shows a small growth in Revenue. The Revenue has been growing by 7.89% on average per year.
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
3.2 Future
Based on estimates for the next years, CLARI will show a very strong growth in Earnings Per Share. The EPS will grow by 39.56% on average per year.
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y170.47%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPS Next 5Y39.56%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.04%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CLARI. In the last year negative earnings were reported.
CLARI is valuated reasonably with a Price/Forward Earnings ratio of 11.98.
Based on the Price/Forward Earnings ratio, CLARI is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.33, CLARI is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.98 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CLARI is valued a bit cheaper than the industry average as 61.29% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaper than 93.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.51 | ||
| EV/EBITDA | 8.56 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLARI's earnings are expected to grow with 58.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.53%
EPS Next 3Y58.66%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 10.64%, CLARI is a good candidate for dividend investing.
CLARI's Dividend Yield is rather good when compared to the industry average which is at 2.52. CLARI pays more dividend than 100.00% of the companies in the same industry.
CLARI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CLARI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.43%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPA:CLARI (10/23/2025, 7:00:00 PM)
4.34
+0.14 (+3.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.41%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.55B
Revenue(TTM)5.31B
Net Income(TTM)-61380000
Analysts77.14
Price Target4.79 (10.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)43.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)10.2%
EPS NY rev (3m)23.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.98 | ||
| P/S | 0.29 | ||
| P/FCF | 2.51 | ||
| P/OCF | 1.75 | ||
| P/B | 0.43 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.56 |
EPS(TTM)-0.17
EYN/A
EPS(NY)0.36
Fwd EY8.35%
FCF(TTM)1.73
FCFY39.91%
OCF(TTM)2.47
OCFY57.01%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROCE | 2.21% | ||
| ROIC | 1.63% | ||
| ROICexc | 1.74% | ||
| ROICexgc | 3.53% | ||
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% | ||
| FCFM | 11.64% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Debt/EBITDA | 6.54 | ||
| Cap/Depr | 33.63% | ||
| Cap/Sales | 4.99% | ||
| Interest Coverage | 0.83 | ||
| Cash Conversion | 84.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 | ||
| Altman-Z | 0.63 |
F-Score6
WACC3.92%
ROIC/WACC0.41
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y170.47%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPS Next 5Y39.56%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.04%
EBIT growth 1Y-22.25%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year302.5%
EBIT Next 3Y65.72%
EBIT Next 5Y38.3%
FCF growth 1Y267.6%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%